Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity
about
Identification of a 24-kDa cytokine that is required for development of cytolytic T lymphocytes.Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndromeAnalysis of prostaglandin E2 effect on T lymphocyte activation. Abrogation of prostaglandin E2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetateCyclosporin a disrupts notch signaling and vascular lumen maintenance.Purification to homogeneity and partial characterization of interleukin 2 from a human T-cell leukemia.Antibodies to interleukin 2. Effects on immune responses in vitro and in vivo.Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytesMolecular cloning of human interleukin 2 cDNA and its expression in E. coli.Rescue of anti-influenza A virus cytotoxic T-lymphocyte responses in chemotherapy-suppressed miceStimulation of lymphoid cell proliferation by Mycoplasma orale, a common cell culture contaminantPurification and partial sequence analysis of human T-cell growth factor.The therapeutic potential of lymphokines in neoplastic disease.Human interleukin 2: biochemistry, physiology, and possible pathogenetic role in immunodeficiency syndromes.The glycoprotein nature and biosynthetic relationship of two molecularly distinct species of primate T-cell growth factor.Natural killer (NK) cell activating factor produced by a human T-cell hybridoma.Characterization of human interleukin 2 derived from Escherichia coli.Response of resting human peripheral blood natural killer cells to interleukin 2.The Role of Tumor Microenvironment in Cancer Immunotherapy.
P2860
Q33557907-2803D73A-FF37-4A72-B295-1E5502758F55Q34192924-C125F923-8295-4837-87BC-9BD8B48FD18FQ34565648-54D1DE5A-0F03-476B-AE92-570278498B49Q35576747-04B86A1B-8831-4A3F-B8C2-7F3778E17526Q35578269-FF166B71-32B2-483A-BF07-B0C8F92F9908Q36254462-BAA15756-F342-4050-A5A8-A316CFF8234DQ36349172-C47B2D5D-7985-4A9D-AD1B-E56B63DAD0A7Q36349586-6791E693-F03F-453E-9C2D-044B0330DAA9Q36597657-5F583FBB-713F-46F0-87DE-EC3E19572A13Q36892330-9FB95289-006A-4526-A991-BF0D57B93431Q37031264-C10B2ED3-2826-4853-AD35-A86F67188D77Q37690155-F373B279-1746-4D42-BC18-4C8EB8E62865Q39644249-31D999F7-5E4D-452F-9822-60912039439FQ39845943-2EC63EB6-0C8B-4407-BE3B-BF573D532278Q41446942-929E517E-C157-48CC-8A58-99E1CD980C0DQ41705814-47557A13-61D9-41F4-BD91-81CF1CC4E001Q41953720-2693112A-B3E1-4AA8-B144-484343CD547DQ42153962-52F3F584-172E-45A4-8507-F8BF52EC819DQ47252754-EAA750A5-7D6B-4E1B-9FD1-92369DEDBC55
P2860
Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity
description
1982 nî lūn-bûn
@nan
1982 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Purification of human interleu ...... nd its molecular heterogeneity
@ast
Purification of human interleu ...... nd its molecular heterogeneity
@en
Purification of human interleu ...... nd its molecular heterogeneity
@nl
type
label
Purification of human interleu ...... nd its molecular heterogeneity
@ast
Purification of human interleu ...... nd its molecular heterogeneity
@en
Purification of human interleu ...... nd its molecular heterogeneity
@nl
prefLabel
Purification of human interleu ...... nd its molecular heterogeneity
@ast
Purification of human interleu ...... nd its molecular heterogeneity
@en
Purification of human interleu ...... nd its molecular heterogeneity
@nl
P2093
P2860
P356
P1476
Purification of human interleu ...... nd its molecular heterogeneity
@en
P2093
P2860
P304
P356
10.1084/JEM.156.2.454
P407
P577
1982-08-01T00:00:00Z